|
Market Closed -
Nasdaq
00:00:00 26/09/2026 +04
|
5-day change | 1st Jan Change | ||
| 11.62 USD | +0.61% |
|
+3.84% | -42.93% |
| 09-09 | Keros Therapeutics Approves $5 Million Share Buyback | MT |
| 09-09 | Keros Therapeutics, Inc. announces an Equity Buyback for $5 million worth of its shares. | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Bio Therapeutic Drugs
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 230M | - | - | - | ||
| 72.26B | |||||
| 60.24B | |||||
| 27.73B | |||||
| 25.73B | - | ||||
| 24.75B | - |
Select your edition
All financial news and data tailored to specific country editions
